<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8909</journal-id>
<journal-title><![CDATA[Medicina crítica (Colegio Mexicano de Medicina Crítica)]]></journal-title>
<abbrev-journal-title><![CDATA[Med. crít. (Col. Mex. Med. Crít.)]]></abbrev-journal-title>
<issn>2448-8909</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Medicina Crítica A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-89092018000500290</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Intoxicación por carbamazepina: reporte de un caso tratado con hemodiálisis de alto flujo]]></article-title>
<article-title xml:lang="en"><![CDATA[Carbamazepine poisoning: case report treated with high-flux hemodialysis]]></article-title>
<article-title xml:lang="pt"><![CDATA[Intoxicação por carbamazepina: relato de um caso tratado com hemodiálise de alto fluxo]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Tuñón]]></surname>
<given-names><![CDATA[Jorge Guillermo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martiñón Ríos]]></surname>
<given-names><![CDATA[Rocío]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Figueroa Rivera]]></surname>
<given-names><![CDATA[Magaly]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bautista Albíter]]></surname>
<given-names><![CDATA[Mayré Ivonne]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Ángeles Lomas  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>32</volume>
<numero>5</numero>
<fpage>290</fpage>
<lpage>294</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-89092018000500290&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-89092018000500290&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-89092018000500290&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: La carbamazepina es un medicamento que en sobredosis puede causar alteraciones neurológicas y cardiovasculares que ponen en peligro la vida, ya sea por efecto directo o por su metabolito activo 10,11-epóxido. En los pacientes intoxicados con carbamazepina que presentan una mala respuesta al tratamiento inicial o una intoxicación severa, puede requerirse el empleo de técnicas extracorpóreas de eliminación como la hemodiálisis o la hemoperfusión. Describimos el caso de una mujer de 71 años que ingirió una sobredosis de carbamazepina, diazepam y zolpidem en un intento suicida, la cual no respondió favorablemente al tratamiento conservador, por lo que fue necesario llevar a cabo dos sesiones de hemodiálisis de alto flujo. Al término de las sesiones, se normalizó la concentración sérica de carbamazepina y la paciente mostró mejoría de su condición clínica. Con el desarrollo de membranas de hemodiálisis de alto flujo, ha sido posible incrementar el aclaramiento de xenobióticos que eran considerados como moderadamente dializables, lo cual podría ampliar las expectativas respecto a la utilidad de la hemodiálisis en el tratamiento de los pacientes intoxicados por éste y otros xenobióticos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Carbamazepine is a drug that in overdose can cause life-threatening neurological and cardiovascular abnormalities, either by direct effect or by its active metabolite 10,11-epoxide. In carbamazepine poisoned patients with poor response to initial treatment or severe poisoning, may require the use of extracorporeal elimination techniques such as hemodialysis or hemoperfusion.We describe the case of a 71-year-old woman who ingested an overdose of carbamazepine, diazepam and zolpidem in a suicide attempt, who did not respond favorably to the conservative treatment, so it was necessary to conduct two sessions of high-flux hemodialysis. At the end of the sessions the serum concentration of carbamazepine was normalized and patient showed improvement in her clinical condition. With the development of high-flux hemodialysis membranes it has been possible to increase the clearance of xenobiotics that were considered as moderately dialyzable, which could extend the expectations regarding the usefulness of hemodialysis in the treatment of poisoned patients by this and other xenobiotics.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo: A carbamazepina é um medicamento que em caso de sobredosagem pode causar alterações neurológicas e cardiovasculares potencialmente fatais, seja por efeito direto ou por seu metabólito ativo 10,11-epóxido. Em pacientes intoxicados com carbamazepina que apresentam uma pobre resposta ao tratamento inicial ou envenenamento grave o uso de técnicas de eliminação extracorpórea como hemodiálise ou hemoperfusão pode ser necessário. Descrevemos o caso de uma mulher de 71 anos que ingeriu uma dose excessiva de carbamazepina, diazepam e zolpidem em uma tentativa de suicídio, que não respondeu favoravelmente ao tratamento conservador, por isso foi necessário realizar duas sessões de hemodiálise de alto fluxo. Ao final das sessões a concentração sérica de carbamazepina foi normalizada e a paciente apresentou melhora em sua condição clínica. Com o desenvolvimento de membranas de hemodiálise de alto fluxo foi possível aumentar a depuração de xenobióticos considerados moderadamente dialisáveis, o que poderia ampliar as expectativas em relação à utilidade da hemodiálise no tratamento de pacientes intoxicados por este e outros xenobióticos.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Carbamazepina]]></kwd>
<kwd lng="es"><![CDATA[intoxicación]]></kwd>
<kwd lng="es"><![CDATA[hemodiálisis]]></kwd>
<kwd lng="en"><![CDATA[Carbamazepine]]></kwd>
<kwd lng="en"><![CDATA[poisoning]]></kwd>
<kwd lng="en"><![CDATA[hemodialysis]]></kwd>
<kwd lng="pt"><![CDATA[Carbamazepina]]></kwd>
<kwd lng="pt"><![CDATA[intoxicação]]></kwd>
<kwd lng="pt"><![CDATA[hemodiálise]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Armijo]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Herranz]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fármacos antiepilépticos y anticonvulsivantes]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Armijo]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Mediavilla]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Farmacología humana]]></source>
<year>2014</year>
<edition>6</edition>
<page-range>476-96</page-range><publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Doyon]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antiepileptics]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Hoffman]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Howland]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Levin]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
</person-group>
<source><![CDATA[Goldfrank&#8217;s toxicologic emergencies]]></source>
<year>2015</year>
<edition>10</edition>
<page-range>1107-12</page-range><publisher-loc><![CDATA[EUA ]]></publisher-loc>
<publisher-name><![CDATA[Mc Graw-Hill]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Spiller]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of carbamazepine overdose]]></article-title>
<source><![CDATA[Pediatr Emerg Care]]></source>
<year>2001</year>
<volume>17</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>452-6</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Winnicka]]></surname>
<given-names><![CDATA[RI]]></given-names>
</name>
<name>
<surname><![CDATA[Topacinski]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Szymczak]]></surname>
<given-names><![CDATA[WM]]></given-names>
</name>
<name>
<surname><![CDATA[Szyma&#324;ska]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Carbamazepine poisoning: elimination kinetics and quantitative relationship with carbamazepine 10,11-epoxede]]></article-title>
<source><![CDATA[J Toxicol Clin Toxicol]]></source>
<year>2002</year>
<volume>40</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>759-65</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vree]]></surname>
<given-names><![CDATA[TB]]></given-names>
</name>
<name>
<surname><![CDATA[Janssen]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hekster]]></surname>
<given-names><![CDATA[YA]]></given-names>
</name>
<name>
<surname><![CDATA[Termond]]></surname>
<given-names><![CDATA[EF]]></given-names>
</name>
<name>
<surname><![CDATA[Van de Dries]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose]]></article-title>
<source><![CDATA[Ther Drug Monit]]></source>
<year>1986</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>297-304</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soderstrom]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Murray]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Little]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Daly]]></surname>
<given-names><![CDATA[FF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Toxicology case of the month: carbamazepine overdose]]></article-title>
<source><![CDATA[Emerg Med J]]></source>
<year>2006</year>
<volume>23</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>869-71</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Panday]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Panday]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Basnet]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kafle]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Rauniar]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Therapeutic drug monitoring of carbamazepine]]></article-title>
<source><![CDATA[Int J Neurorehabiltation]]></source>
<year>2017</year>
<volume>4</volume>
<numero>245</numero>
<issue>245</issue>
<page-range>1-5</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benson]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
<name>
<surname><![CDATA[Hoppu]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Troutman]]></surname>
<given-names><![CDATA[WG]]></given-names>
</name>
<name>
<surname><![CDATA[Bedry]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Erdman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Höger]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Position paper update: gastric lavage for gastrointestinal decontamination]]></article-title>
<source><![CDATA[Clin Toxicol (Phila)]]></source>
<year>2013</year>
<volume>51</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>140-6</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brahmi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Kouraichi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Thabet]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Amamou]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning]]></article-title>
<source><![CDATA[Am J Emerg Med]]></source>
<year>2006</year>
<volume>24</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>440-3</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mise]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Juki&#263;]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Tonki&#263;]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Titli&#263;]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mise]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multidose activated charcoal in the treatment of carbamazepine overdose with seizures: a case report]]></article-title>
<source><![CDATA[Arh Hig Rada Toksikol]]></source>
<year>2005</year>
<volume>56</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>333-8</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brodie]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mintzer]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pack]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Gidal]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
<name>
<surname><![CDATA[Vecht]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Schmidt]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enzyme induction with antiepileptic drugs: cause for concern?]]></article-title>
<source><![CDATA[Epilepsia]]></source>
<year>2013</year>
<volume>54</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>11-27</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dalton]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Powell]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Messenheimer]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cimetidine and carbamazepine: a complex drug interaction]]></article-title>
<source><![CDATA[Epilepsia]]></source>
<year>1986</year>
<volume>27</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>553-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4]]></article-title>
<source><![CDATA[Ther Clin Risk Manag]]></source>
<year>2005</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-13</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Macphee]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[GG]]></given-names>
</name>
<name>
<surname><![CDATA[Scobie]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Agnew]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[BK]]></given-names>
</name>
<name>
<surname><![CDATA[Murray]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of cimetidine on carbamazepine auto- and hetero-induction in man]]></article-title>
<source><![CDATA[Br J Clin Pharmacol]]></source>
<year>1984</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>411-9</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cameron]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hungerford]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Dawson]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of charcoal hemoperfusion in massive carbamazepine poisoning]]></article-title>
<source><![CDATA[J Toxicol Clin Toxicol]]></source>
<year>2002</year>
<volume>40</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>507-12</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kielstein]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
<name>
<surname><![CDATA[Schwarz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Arnavaz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sehlberg]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Emrich]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Fliser]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-flux hemodialysis-an effective alternative to hemoperfusion in the treatment of carbamazepine intoxication]]></article-title>
<source><![CDATA[Clin Nephrol]]></source>
<year>2002</year>
<volume>57</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>484-6</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Payette]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ghannoum]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Madore]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Albert]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Troyanov]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bouchard]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Carbamazepine poisoning treated by multiple extracorporeal treatments]]></article-title>
<source><![CDATA[Clin Nephrol]]></source>
<year>2015</year>
<volume>83</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>184-8</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harder]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Heung]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vilay]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Mueller]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Segal]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Carbamazepine and the active epoxide metabolite are effectively cleared by hemodialysis followed by continuous venovenous hemodialysis in an acute overdose]]></article-title>
<source><![CDATA[Hemodial Int]]></source>
<year>2011</year>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>412-5</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ghannoum]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Yates]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Galvao]]></surname>
<given-names><![CDATA[TF]]></given-names>
</name>
<name>
<surname><![CDATA[Sowinski]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Vo]]></surname>
<given-names><![CDATA[TH]]></given-names>
</name>
<name>
<surname><![CDATA[Coogan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hoffman RS, EXTRIP workgroup. Extracorporeal treatment for carbamazepine poisoning: systematic review and recommendations from the EXTRIP workgroup]]></article-title>
<source><![CDATA[Clin Toxicol (Phila)]]></source>
<year>2014</year>
<volume>52</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>993-1004</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ozhasenekler]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gökhan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gülo&#287;lu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Orak]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ustünda&#287;]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benefit of hemodialysis in carbamazepine intoxications with neurological complications]]></article-title>
<source><![CDATA[Eur Rev Med Pharmacol Sci]]></source>
<year>2012</year>
<volume>16</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>43-7</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gummin]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Mowry]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Spyker]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Brooks]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Fraser]]></surname>
<given-names><![CDATA[MO]]></given-names>
</name>
<name>
<surname><![CDATA[Banner]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2016 Annual Report of the American Association of Poison Control Centers&#8217; National Poison Data System (NPDS): 34th Annual Report]]></article-title>
<source><![CDATA[Clin Toxicol]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bouchard]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Roy]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ouellet]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Decker]]></surname>
<given-names><![CDATA[BS]]></given-names>
</name>
<name>
<surname><![CDATA[Mueller]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Principles and operational parameters to optimize poison removal with extracorporeal treatments]]></article-title>
<source><![CDATA[Semin Dial]]></source>
<year>2014</year>
<volume>27</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>371-80</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sikma]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Van den Broek]]></surname>
<given-names><![CDATA[MPH]]></given-names>
</name>
<name>
<surname><![CDATA[Meulenbelt]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Increased unbound drug fraction in acute carbamazepine intoxication: suitability and effectiveness of high-flux haemodialysis]]></article-title>
<source><![CDATA[Intensive Care Med]]></source>
<year>2012</year>
<volume>38</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>916-7</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chetty]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sarkar]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Aggarwal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sakhuja]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Carbamazepine poisoning: treatment with haemodialysis]]></article-title>
<source><![CDATA[Nephrol Dial Transplant]]></source>
<year>2003</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>220-1</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vallianou]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Giannopoulou]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Trigkidis]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Bei]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Margellou]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Apostolou]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A case of severe carbamazepine overdose treated successfully with combined hemoperfusion and hemodialysis technique]]></article-title>
<source><![CDATA[Saudi J Kidney Dis Transpl]]></source>
<year>2017</year>
<volume>28</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>906-8</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koh]]></surname>
<given-names><![CDATA[KH]]></given-names>
</name>
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[HH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-flux haemodialysis treatment as treatment for carbamazepine intoxication]]></article-title>
<source><![CDATA[Med J Malaysia]]></source>
<year>2006</year>
<volume>61</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>109-11</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Isik]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Soyoral]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Karadas]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Emre]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Bilal]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Goktas]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effectivity of one session charcoal hemoperfusion treatment in severe carbamazepine poisoning]]></article-title>
<source><![CDATA[Iran Red Crescent Med J]]></source>
<year>2013</year>
<volume>15</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>749-51</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pilapil]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Peterson]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of hemodialysis and charcoal hemoperfusion in carbamazepine overdose]]></article-title>
<source><![CDATA[Clin Toxicol (Phila)]]></source>
<year>2008</year>
<volume>46</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>342-3</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
